Literature DB >> 29471514

Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines.

M Aapro1, Y Beguin2,3, C Bokemeyer4, M Dicato5, P Gascón6, J Glaspy7, A Hofmann8, H Link9, T Littlewood10, H Ludwig11, A Österborg12, P Pronzato13, V Santini14, D Schrijvers15, R Stauder16, K Jordan17, J Herrstedt18,19.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29471514     DOI： 10.1093/annonc/mdx758

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  32 in total

Review 1.  Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.

Authors:  Frederik Soetaert; Preethi Korangath; David Serantes; Steven Fiering; Robert Ivkov
Journal:  Adv Drug Deliv Rev       Date:  2020-06-27       Impact factor: 15.470

2.  Talazoparib in Patients with a Germline BRCA-Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial.

Authors:  Sara A Hurvitz; Anthony Gonçalves; Hope S Rugo; Kyung-Hun Lee; Louis Fehrenbacher; Lida A Mina; Sami Diab; Joanne L Blum; Jayeta Chakrabarti; Mohamed Elmeliegy; Liza DeAnnuntis; Eric Gauthier; Akos Czibere; Iulia Cristina Tudor; Ruben G W Quek; Jennifer K Litton; Johannes Ettl
Journal:  Oncologist       Date:  2019-11-25

3.  Iron deficiency during first-line chemotherapy in metastatic cancers: a prospective epidemiological study.

Authors:  Angélique Saint; J Viotti; D Borchiellini; B Hoch; V Raimondi; C Hebert; R Largillier; L Evesque; P Follana; J M Ferrero; C Delaby; R Schiappa; E Chamorey; J Barriere
Journal:  Support Care Cancer       Date:  2019-07-06       Impact factor: 3.603

4.  Effects of micronised microencapsulated ferric pyrophosphate supplementation in patients with advanced cancer and iron deficiency: a single-centre cohort pilot study.

Authors:  Alessandro Pappalardo; Walter Currenti; Rossella Ponzio; Giulio Mellini; Daniela Nicolosi; Lucia Longhitano; Daniele Tibullo; Sergio Castorina; Giuseppe Palumbo
Journal:  Blood Transfus       Date:  2019-02-18       Impact factor: 3.443

5.  Randomized trial of sucrosomial iron supplementation in patients with chemotherapy-related anemia treated with ESA.

Authors:  Andrea Zuccarini; Daniela Cicognini; Richard Tancredi; Alessandra Ferrari; Gianpiero Rizzo; Angioletta Lasagna; Riccardo Caccialanza; Luigi Cavanna; Elena Orlandi; Claudia Biasini; Peppina Molinaro; Danula Garigliano; Angela Costantino; Mauro Moroni; Lorenzo Perrone; Niccolò Leandro Alessio; Bianca Rovati; Virginia Valeria Ferretti; Catherine Klersy; Paolo Pedrazzoli
Journal:  Support Care Cancer       Date:  2022-06-09       Impact factor: 3.359

6.  Postoperative patient blood management: transfusion appropriateness in cancer patients.

Authors:  Lucia Merolle; Chiara Marraccini; Erminia Di Bartolomeo; Maria T Montella; Thelma A Pertinhez; Roberto Baricchi; Alessandro Bonini
Journal:  Blood Transfus       Date:  2020-07-22       Impact factor: 3.443

Review 7.  Hematopoietic Growth Factors in the Management of Anemia and Febrile Neutropenia.

Authors:  Hartmut Link
Journal:  Breast Care (Basel)       Date:  2019-03-14       Impact factor: 2.860

Review 8.  Management of Adverse Events During Rucaparib Treatment for Relapsed Ovarian Cancer: A Review of Published Studies and Practical Guidance.

Authors:  Domenica Lorusso; Jesús García-Donas; Jalid Sehouli; Florence Joly
Journal:  Target Oncol       Date:  2020-06       Impact factor: 4.493

Review 9.  Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era.

Authors:  Gary H Lyman; Nicole M Kuderer; Matti Aapro
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

Review 10.  Ironing out mechanisms of iron homeostasis and disorders of iron deficiency.

Authors:  Navid Koleini; Jason S Shapiro; Justin Geier; Hossein Ardehali
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.